Evidence map›Paper›PMID 42236988›Full record

ArticleNature microbiology2026

IL-22 promotes genesis of small intestinal secretory cells that protect against cholera in mice.

Masataka Suzuki, Yuko Hasegawa, Hailong Zhang, Zhu Liang, Guodong Tie, Ramesh A Shivdasani, Matthew K Waldor

Abstract read
In one paragraph

Article in Nature microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Masataka SuzukiDepartment of Microbiology, Harvard Medical School, Division of Infectious Diseases, Brigham and Women's Hospital, Howard Hughes Medical Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0001-5352-8595
Yuko HasegawaDepartment of Microbiology, Harvard Medical School, Division of Infectious Diseases, Brigham and Women's Hospital, Howard Hughes Medical Institute, Boston, MA, USA.
Hailong ZhangDepartment of Microbiology, Harvard Medical School, Division of Infectious Diseases, Brigham and Women's Hospital, Howard Hughes Medical Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0002-4903-010X
Zhu LiangDepartment of Microbiology, Harvard Medical School, Division of Infectious Diseases, Brigham and Women's Hospital, Howard Hughes Medical Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0001-8223-5003
Guodong TieDepartment of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.
Ramesh A ShivdasaniDepartment of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0002-2828-1727
Matthew K WaldorDepartment of Microbiology, Harvard Medical School, Division of Infectious Diseases, Brigham and Women's Hospital, Howard Hughes Medical Institute, Boston, MA, USA. mwaldor@research.bwh.harvard.edu.ORCID http://orcid.org/0000-0003-1843-7000

Funding

Vibrio cholerae intestinal colonization and vaccine developmentR01AI042347 · NIAID · TUFTS UNIVERSITY BOSTON · PI WALDOR, MATTHEW K · 1998 to 2025
$7.3M
Transcriptional control and enhancer recruitment in mouse and human intestinal secretory differentiationR01DK082889 · NIDDK · DANA-FARBER CANCER INST · PI Ramesh A Shivdasani · 2010 to 2026
$5.2M
Howard Hughes Medical InstituteNIAID NIH HHS R01 AI042347NIDDK NIH HHS R01 DK082889U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI042347U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) R01DK082889
6 · The paper itself

Abstract

The diarrhoeal disease cholera remains a global threat, but there is limited knowledge of the innate immune defences in the small intestine that protect against the causative agent, Vibrio cholerae. Here single-cell RNA sequencing of epithelial and immune cells mapped gene expression patterns in the infant mouse small intestine and revealed changes in response to V. cholerae infection and prophylactic treatment with an interleukin-22-immunoglobulin Fc region (IL-22Fc)-fusion protein. Infection increased the abundance of an enterocyte subtype with high expression of defence-associated functions and stimulated production of IL-22, a cytokine linked to epithelial integrity, from group 3 innate lymphoid cells. Administration of IL-22Fc increased production of vibriocidal Reg3β from enterocytes and the abundance of secretory lineage and Muc2-producing goblet cells, which secreted mucus into the intestinal crypts, impairing V. cholerae association with the epithelium. These IL-22-mediated responses limited V. cholerae intestinal colonization and protected mice from diarrhoea and death. Our findings suggest enterocyte specialization in mucosal defence.

Indexed as

CholeraInterleukinsIntestine, SmallVibrio choleraeAnimalsDisease Models, AnimalEnterocytesGoblet CellsImmunity, InnateInterleukin-22Intestinal MucosaMiceMice, Inbred C57BLMucin-2Pancreatitis-Associated ProteinsInterleukin-22InterleukinsMuc2 protein, mouseMucin-2Pancreatitis-Associated ProteinsReg3b protein, mouse

Identifiers

PMID42236988
PMCPMC13310123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.